Factors Predicting Outcome in Stroke Patients Treated With 0.6 mg/kg Alteplase: Evidence From the Japan Alteplase Clinical Trial (J-ACT)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Factors Predicting Outcome in Stroke Patients Treated With 0.6 mg/kg Alteplase: Evidence From the Japan Alteplase Clinical Trial (J-ACT)

Authors:	Etsuro Mori MD Kazuo Minematsu MD Jyoji Nakagawara MD Takenori Yamaguchi MD Japan Alteplase Clinical Trial Group

Affiliation:	^∗Department of Behavioral Neurology and Cognitive Neuroscience, Tohoku University Graduate School of Medicine, Sendai, Japan;^†Cerebrovascular Division, National Cardiovascular Center, Suita, Japan;^‡Department of Neurosurgery and Stroke Center, Nakamura Memorial Hospital, Sapporo, Japan;^§National Cardiovascular Center, Suita, Japan

Abstract:

Keywords:	Acute ischemic stroke acute stroke outcome clinical trial thrombolysis tissue plasminogen activator thrombolysis-associated hemorrhage clinical outcome
本文献已被 ScienceDirect 等数据库收录！